Ligand · MMI
MMI · N-[(4S,5S,7R)-8-({(S)-1-[(benzylamino)oxomethyl]-2-methylpropyl}amino)-5-hydroxy-2,7-dimethyl-8-oxo-oct-4-yl]-(4S,7S)-4 -isopropyl-2,5,9-trioxo-1-oxa-3,6,10-triazacyclohexadecane-7-carboxamide
MMI, N-[(4S,5S,7R)-8-({(S)-1-[(benzylamino)oxomethyl]-2-methylpropyl}amino)-5-hydroxy-2,7-dimethyl-8-oxo-oct-4-yl]-(4S,7S)-4 -isopropyl-2,5,9-trioxo-1-oxa-3,6,10-triazacyclohexadecane-7-carboxamide (C38 H62 N6 O8, 730.9 g/mol), in the…
- Component
- MMI
- Formula
- C38 H62 N6 O8
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
MMI in 2 structures; the first of them:
- 1XS7 · Crystal Structure of a cycloamide-urethane-derived novel inhibitor bound to human brain… · MMI D386 · binds LEU30, ASP32, GLY34, SER35, PRO70, TYR71, THR72, GLN73 and 12 more
- 1XS7 · Crystal structure of a cycloamide-urethane-derived novel inhibitor bound to human brain… · MMI D386 · binds LEU30, ASP32, GLY34, SER35, PRO70, TYR71, THR72, GLN73 and 12 more
Residues it binds most
THR 2, ARG 2, ASP 2, GLY 2, ILE 2, TYR 2, ASN 2, GLN 2, LEU 2, PHE 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.